Jiménez-Domínguez R, Flores VB, Lazcano MML, Flores LI

Language: Spanish
References: 32
Page: 100-112
PDF size: 629.54 Kb.

ABSTRACT

The clinical evaluation and the nerve conduction studies are an essential Part for the evaluation of the Patient with peripheral Polyneuropathy. The nerve conduction studies are important for the diagnosis, classification, treatment and prognosis. We review the relevant aspects in the clinical evaluation and the interpretation of the nerve conduction studies in the Patient with Polyneuropathy. We also describe the clinical and electrophysiological findings of some types of Polyneuropathies.

REFERENCES

1. Fraser JL, Olney RK. The relative diagnostic sensitivity of different F-Wave parameters in various polyneuropathies. Muscle and Nerve 1992;15:912-918.

2. Weber F. Conduction block and abnormal temporal dispersion--diagnostic criteria. Electromyogr Clin Neurophysiol 1997 Aug;37(5):305-9.

3. Richard KO.Consensus criteria for the diagnosis of partial conduction block. Muscle Nerve 1999; 22 Supplement 8: 225-229.

4. Vrancken AFJE, Franssen H, Wokke JHJ, Tenunissen LL, Notermans NC. Chronic idiopathic axonal polyneuropathy and successful aging of the peripheral nervous system in elderly people. Arch Neurol 2002; 59: 533-540.

5. Logigian EL, Kelly Jr. JJ, Adelman LS. Nerve conduction and biopsy correlation in over 100 consecutive patientis with suspected polyneuropathy. Muscle Nerve 1994;17:1010-1020.

6. Van Asseldonk JTH. Van den Berg LH, Kalmijn S, Wokke JHJ, Franssen H. Criteria for demyelination based on the maximum slowing due to axonal degeneration, determined after warming in water at 37 grad celcius:diagnostic yield in chronic inflammatory demyelinating polyneuropathy. Brain 2005;128:880-891.

7. Johannsen L, Smith T, Havsager AM, et al. Evaluation of patients with symptoms suggestive of chronic polyneuropathy. J Clin Neuromuscul Dis 2001; 3: 47-52.

8. Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL. Diabetic neuropathy:clinical maniestations and current treatments. Lancet Neurol 2012;11; 521-34.

9. Escobar-Rodríguez DA, Rivera-Ibarra DB, Juárez-López MJ, González-Carmona B. Utilidad de la electroneuromiografía para evaluar neuropatía en pacientes diabéticos. Rev Med Inst Mex Seguro Soc 2006; 44 (1): 27-34.

10. Bagai K, Wilson JR, Khanna M, Song Y, Wang L, Fisher MA.Electrophysiological patterns of diabetic polyneuropathy. Electromyogr Clin Neurophysiol. 2008; 48(3-4):139-45.

11. Zúñiga-González EA, Rodríguez de la Cruz A, Millán-Padilla J. Subtipos electrofisiológicos del síndrome de Guillain Barré en adultos mexicanos. Rev Med Inst Mex Seguro Soc 2007;45 (5):463- 468.

12. Seneviratne U. Guillain-Barré Syndrome: Clinicopathological Types and Electrophysiological Diagnosis. SGH PROCEEDINGS 2003;12(1):12-15.

13. Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka KV, et al. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/ Sandoglobulin Guillain-Barré Syndrome Trial Group. Ann Neurol 1998; 44:780-8.

14. Geetanjali S, Sushma S, Sudhir S.Early Electodiagnostic Findings of Guillain-Barré Syndrom. J Neurol Neurophysiol 2013; 4(1):1-3.

15. Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/ Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. First Revision Journal of the Peripheral Nervous System 2010; 15:1–9.

16. Point Task Force of the EFNS and the PNS. European Federation of Neurological Societies/ Peripheral Nerve Society Guideline on management of multifocal motor neuropathy. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision. Journal of the Peripheral Nervous System 2010;15:295–301.

17. Collins MP, Dyck PJB, Gronseth GS, et.al. Peripheral Nerve Society Guideline on the classification, diagnosis, investigation, and immunsupressive therapy of non-systemic vasculitic neuropathy:executive summary. J Periph Nerv Syst 2010; 15: 176-84.

18. Gwathmey KG, Burns TM, Collins MP, Dyck PJB. Vasculitic neuropathies. Lancet Neurol 2014;13:67-82.

19. Martyn CN, Hughes RAC. Epidemiology of periipheral neuropathy. J Neurol Neurosurg Psychiatry 1997;62:310-318.

20. Pareysib D, Scaioli V, Laurà M. Clinical and Electrophysiological Aspects of Charcot-Marie-Tooth Disease. NeuroMolecular Medicine 2006;8:3-22.

21. Alcoholic neuropathy: possible mechanisms and future treatment possibilities. Kanwaljit Chopra, Vinod Tiwari. Br J Clin Pharmacol. 2012 Mar; 73(3): 348–362.

22. Lacomis D. Neuromuscular disorders in critically ill patients: review and update. J Clin Neuromuscular Dis. 2011;12(4):197-218

23. Bolton CF. Neuromuscular manifestations of criticall illness. Muscle Nerve 2005; 32:140-63

24. Latronico N, Bolton CF. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol 2011;10:931-41

25. Üceyler N, Sommer C. Small fiber Neuropathien. Akt Neurol 2013;40:96-100

26. Verghese J, Bieri PL, Gellido C, Schaumburg HH, Herskovitz S. Peripheral neuropathy in young-old and old-old patients. Muscle Nerve 2001; 24: 1476–81.

27. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol 2012;11:521- 34

28. Schramm A, Reiners K. Neurophysiologische Untersuchungen in der Diagnostik von Polyneuropathien. Klein Neurophysiol 2007;38:1-11

29. Schulte-Mattler WJ.Antikörpervermittelte Neuropathien. Klin Neurophysiol 2014;45:186-192

30. Mallik A, Weir AI. Nerve conduction studies: Essentials and pitfalls in practice.J Neurol Neurosurg Psychiatry 2005;76 (Suppl II):ii23-ii31

31. Bufler J. Chronische Immunneuropathien: klinisches Spektrum, Diagnostik, Therapie. Klin Neurophysiol 2011;42:1-7

32. Bischoff C, Straube A. Leitlinien klinische Neurophysiologie. 1. Auflage Kohlhammer 2014.